Dosage Form Performance

Dosage Form Performance is the academic concept referring to the measurable rate and extent of drug release and availability from a pharmaceutical formulation, distinguishing it from related concepts by emphasizing the functional behavior of the dosage form in delivering the therapeutic agent under defined physiological conditions.

219

Publications

7.6K

Citations

801

Authors

283

Institutions

Publications per year

2017–2026

44

Authors

801

  1. JK
    Johannes Kraemer

    Eli Lilly (United States), United States

    3 publications · 47 citations

    3

    h-index

  2. HW
    Henderik W. Frijlink

    University of Groningen, Netherlands

    3 publications · 47 citations

    3

    h-index

  3. CV
    Chris Vervaet

    Ghent University, Belgium

    3 publications · 152 citations

    3

    h-index

  4. BC
    Bruno C. Hancock

    Pfizer (United States), United States

    3 publications · 173 citations

    3

    h-index

  5. PB
    Paul B. Myrdal

    University of Arizona, United States

    3 publications · 107 citations

    3

    h-index

1–5 of 801

Venues

  1. International Journal of Pharmaceutics

    32 publications · 1.5K citations

    23

    h-index

  2. Journal of Pharmaceutical Sciences

    21 publications · 852 citations

    16

    h-index

  3. PubMed

    Repository · 12 publications · 378 citations

    11

    h-index

  4. Pharmaceutical Research

    10 publications · 561 citations

    10

    h-index

  5. Drug Development and Industrial Pharmacy

    11 publications · 323 citations

    10

    h-index

1–5